Abstract |
A rare case of primary intestinal T-cell lymphoma (ITL) of an 8-year-old boy is reported. Medium- to large-sized tumor cells were betaF1+, CD3+, CD8+. TIA-1+, but CD4-, CD5-, CD30-, CD56-, CD20-, CD79a-, TdT-, consistent with an intraepithelial lymphocyte (IEL) origin. They showed monoclonal rearrangement of the T-cell receptor gamma-chain and no evidence of EBV infection. No clinical, histologic, laboratory, or genetic evidence of celiac disease was detected. In adults, ITL is often associated with enteropathy and has a very poor outcome. Our patient remains in first remission 30 months after finishing the acute lymphoblastic leukemia protocol COALL-07-03 high risk standard.
|
Authors | Carsten Friedrich, Johanna Schrum, Andreas Chott, Gritta Janka-Schaub, Hartmut Kabisch |
Journal | Pediatric blood & cancer
(Pediatr Blood Cancer)
Vol. 54
Issue 4
Pg. 610-2
(Apr 2010)
ISSN: 1545-5017 [Electronic] United States |
PMID | 20049930
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Receptors, Antigen, T-Cell, gamma-delta
- Cytarabine
- Vincristine
- Etoposide
- Dexamethasone
- Doxorubicin
- Cyclophosphamide
- Mercaptopurine
- Thioguanine
- Methylprednisolone
- Methotrexate
- Daunorubicin
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Child
- Cyclophosphamide
(administration & dosage)
- Cytarabine
(administration & dosage)
- Daunorubicin
(administration & dosage)
- Dexamethasone
(administration & dosage)
- Doxorubicin
(administration & dosage)
- Etoposide
(administration & dosage)
- Humans
- Intestinal Neoplasms
(drug therapy, genetics, pathology)
- Lymphoma, T-Cell
(drug therapy, genetics, pathology)
- Male
- Mercaptopurine
(administration & dosage)
- Methotrexate
(administration & dosage)
- Methylprednisolone
(administration & dosage)
- Neoplasm Staging
- Receptors, Antigen, T-Cell, gamma-delta
(genetics)
- Remission Induction
- Thioguanine
(administration & dosage)
- Vincristine
(administration & dosage)
|